Personalized medicine 2014: LDT guidance, more PGx drugs, changing business models, lawsuits galore
from Genome Web
Whatever happened in the field of personalized medicine over the last 12 months, the U.S. Food and Drug Administration-issued plan for regulating laboratory developed tests has stolen the spotlight. The FDA's long-stated intent to regulate LDTs has been and continues to be a divisive, hot-button topic.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063